Stocktoria
TANDEM DIABETES CARE INC TNDM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-11-13
TANDEM DIABETES CARE INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $940.2M | $747.7M | $801.2M | $702.8M |
| Gross profit | $546.0M | $489.6M | $367.7M | $413.0M | $376.2M |
| R&D expense | — | — | — | — | $92.1M |
| SG&A expense | $445.0M | $389.8M | $352.5M | $335.7M | $261.5M |
| Operating income | -$187.3M | -$99.1M | -$233.2M | -$92.8M | $22.7M |
| Income tax | $4.4M | $4.2M | $2.4M | $1.7M | $335,000 |
| Net income | -$204.7M | -$96.0M | -$222.6M | -$94.6M | $15.6M |
| EPS (diluted) | $-3.04 | $-1.47 | $-3.43 | $-1.47 | $0.24 |
| Operating cash flow | -$9.7M | $24.2M | -$31.8M | $50.5M | $111.4M |
| Free cash flow | -$29.7M | $5.0M | -$58.6M | $16.4M | $97.2M |
| Cash & equivalents | $90.6M | $69.2M | $58.9M | $172.5M | $71.2M |
| Inventory | $128.8M | $149.6M | $157.9M | $111.1M | $68.6M |
| Total assets | $881.1M | $967.7M | $952.7M | $1.1B | $905.1M |
| Total liabilities | $725.9M | $704.6M | $639.0M | $612.8M | $472.0M |
| Shareholders' equity | $155.2M | $263.1M | $313.6M | $439.9M | $433.1M |
Source: SEC EDGAR filings · CIK 0001438133 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.